Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
DRUG ALERT
CLASS 2 MEDICINES RECALLPHARMACY LEVEL RECALL
| 04 March 2010 | EL (10)A/04 | Our ref: MDR 09-03/10 |
Dear Healthcare Professional,
Winthrop Pharmaceuticals UK
Alimemazine Tartrate 7.5mg/5ml Syrup
| Batch Number | Expiry Date | Pack Size | First Distributed |
| BN4 | October 2012 | 1x100 ml | 27 November 2009 |
Winthrop Pharmaceuticals UK limited is recalling all remaining stocks of the above batch of Alimemazine Tartrate 7.5 mg/5 ml Syrup. This action is being taken as a precautionary measure because the company has become aware that there is the potential for a bottle of 30 mg/5 ml syrup to be found in a carton labelled for 7.5 mg/5 ml syrup. To date, only one such pack has been identified.
(Please note, there is a batch of 30mg/5ml syrup with the same batch number, BN4. This is not being recalled.)
Pharmacists are asked to return any stock from this batch via the appropriate wholesaler. For any stock enquiries, please contact Winthrop customer service on 0800 854431
For medical information enquiries please contact Winthrop Pharmaceuticals UK Ltd medical information on 01483 554101
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Primary care trusts are asked to forward this to relevant clinics and to general practitioners and community pharmacists for information.
Yours faithfully
Alison Bunce
Pharmaceutical Assessor DMRC
Regional contacts for NHS trusts and provider units
Chief pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special hospitals
Healthcare Commission for distribution to independent health care establishments
Primary care trusts (England)

